Expert insights from EASL 2026: Dr. Debbie Shawcross shares her thoughts on the future of liver disease management and the latest developments in the field.
Category: Liver Disease
Exclusive Interview: Debbie Shawcross Shares Insights on the Future of Liver Disease Treatment
Learn about the latest advancements in liver disease treatment from Debbie Shawcross at EASL 2026, and discover the future of hepatology.
Early Risk Prediction in Paediatric PSC: The Importance of GGT Trajectories
Learn how monitoring gamma-glutamyl transferase (GGT) trajectories may enhance early risk prediction for paediatric primary sclerosing cholangitis (PSC).
